Cementos Bio-B (CEMENTOS) - Total Assets
Based on the latest financial reports, Cementos Bio-B (CEMENTOS) holds total assets worth CL$528.13 Billion CLP (≈ $590.64 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Cementos Bio-B (CEMENTOS) net assets for net asset value and shareholders' equity analysis.
Cementos Bio-B - Total Assets Trend (2014–2025)
This chart illustrates how Cementos Bio-B's total assets have evolved over time, based on quarterly financial data.
Cementos Bio-B - Asset Composition Analysis
Current Asset Composition (December 2025)
Cementos Bio-B's total assets of CL$528.13 Billion consist of 32.9% current assets and 67.1% non-current assets.
| Asset Category | Amount (CLP) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CL$0.00 | 8.2% |
| Accounts Receivable | CL$59.38 Billion | 11.2% |
| Inventory | CL$53.76 Billion | 10.2% |
| Property, Plant & Equipment | CL$0.00 | 0.0% |
| Intangible Assets | CL$3.51 Billion | 0.7% |
| Goodwill | CL$12.48 Billion | 2.4% |
Asset Composition Trend (2014–2025)
This chart illustrates how Cementos Bio-B's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Cementos Bio-B stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cementos Bio-B's current assets represent 32.9% of total assets in 2025, an increase from 22.9% in 2014.
- Cash Position: Cash and equivalents constituted 8.2% of total assets in 2025, up from 3.7% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, unchanged from 2.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 11.2% of total assets.
Cementos Bio-B Competitors by Total Assets
Key competitors of Cementos Bio-B based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Brickworks Ltd
AU:BKW
|
Australia | AU$5.78 Billion |
|
Sinostone Guangdong Co Ltd
SHE:001212
|
China | CN¥2.25 Billion |
|
Ningxia Building Materials Group Co Ltd
SHG:600449
|
China | CN¥9.79 Billion |
|
Hubei Sanxia New Building Materials Co Ltd
SHG:600293
|
China | CN¥3.30 Billion |
|
Sagar Cements Limited
NSE:SAGCEM
|
India | Rs43.96 Billion |
|
Melon SA
SN:MELON
|
Chile | CL$378.61 Billion |
|
Semen Baturaja Persero Tbk
JK:SMBR
|
Indonesia | Rp4.80 Trillion |
|
Mangalam Cement Limited
NSE:MANGLMCEM
|
India | Rs23.50 Billion |
Cementos Bio-B - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.38 | 1.29 | 1.92 |
| Quick Ratio | 0.95 | 0.85 | 1.39 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CL$47.69 Billion | CL$33.76 Billion | CL$57.15 Billion |
Cementos Bio-B - Advanced Valuation Insights
This section examines the relationship between Cementos Bio-B's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.59 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 1.3% |
| Total Assets | CL$528.13 Billion |
| Market Capitalization | $511.20 Million USD |
Valuation Analysis
Below Book Valuation: The market values Cementos Bio-B's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Cementos Bio-B's assets grew by 1.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Cementos Bio-B (2014–2025)
The table below shows the annual total assets of Cementos Bio-B from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CL$528.13 Billion ≈ $590.64 Million |
+1.28% |
| 2024-12-31 | CL$521.44 Billion ≈ $583.15 Million |
+6.13% |
| 2023-12-31 | CL$491.32 Billion ≈ $549.47 Million |
+3.27% |
| 2022-12-31 | CL$475.75 Billion ≈ $532.05 Million |
-2.68% |
| 2021-12-31 | CL$488.87 Billion ≈ $546.72 Million |
+9.57% |
| 2020-12-31 | CL$446.18 Billion ≈ $498.98 Million |
+1.78% |
| 2019-12-31 | CL$438.37 Billion ≈ $490.25 Million |
-2.50% |
| 2018-12-31 | CL$449.61 Billion ≈ $502.82 Million |
+2.27% |
| 2017-12-31 | CL$439.61 Billion ≈ $491.64 Million |
-8.09% |
| 2016-12-31 | CL$478.33 Billion ≈ $534.93 Million |
-0.25% |
| 2015-12-31 | CL$479.54 Billion ≈ $536.29 Million |
-5.88% |
| 2014-12-31 | CL$509.47 Billion ≈ $569.77 Million |
-- |
About Cementos Bio-B
Cementos Bio Bio S.A. engages in the production and sale of cement, lime, and concrete products in Chile and internationally. The company operates through Cement and Lime segments. It offers ready-mixed concrete, gypsum, and limestone products. The company is also involved in the manufacture and sale of lime for use in the extraction of silver, gold, lithium, and iodine applications, as well as c… Read more